Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 4

Status

Recruiting 2Withdrawn 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 4

Conditions

Glioma 4Glioblastoma 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Neoplasms 1Carcinoma, Transitional Cell 1

Interventions

Magnetic Resonance Spectroscopy 7Temozolomide 6Radiotherapy 6fluciclovine F-18 4Topotecan 4fluorodopa F 18 3Biopsy 3niraparib 2abemaciclib 2Standard of Care 2Specimen Handling 2Pemetrexed 2Ketoconazole 2ulixertinib 1temsirolimus 1ribociclib 1posaconazole 1poly ICLC 1pitavastatin 1pembrolizumab 1orludodstat 1lorlatinib 1larotrectinib 1infigratinib 1fisetin 1fimepinostat 1evolocumab 1clevudine 1X-Rays 1Watchful Waiting 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Glioma × fluciclovine F-18 × Clear all
NCT05555550 2026-04-29

Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG

Children's Hospital of Philadelphia

Phase EARLY_PHASE1 Recruiting
30 enrolled
CNS

Glioma

NCT05553041 2025-12-04

18F-Fluciclovine PET-MRI in High-grade Glioma

Children's Hospital of Philadelphia

Phase EARLY_PHASE1 Recruiting
30 enrolled
CNS

Glioma

NCT05054400 2023-09-01

Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Withdrawn
CNS

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms

NCT04114370 2022-12-06

FACBC

University of Pittsburgh

Phase EARLY_PHASE1 Completed
9 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡